- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-08-0006774

About A.S.Pharma Private Limited
Data last updated:
A.S.Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 28 September 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PTC141246. Its GSTIN is 07AAFCA5703N1ZK (Delhi). The company holds 10 GST registrations, of which 9 are active.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹34.27 Lakh. It is led by directors including Ajay Dudeja and Santosh Kumar Dudeja.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D – 10/7 Okhla Industrial Area, Phase – 2, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹255.15 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.98 Cr (net margin 1.2%) and EBITDA of ₹10.8 Cr (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 19% over five years.
The company has about 25 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: AS Pharma. As per MCA filings, the company has open charges of ₹89.06 Cr and satisfied charges of ₹5 Cr on record. Court records list 42 cases involving the company, including 27 filed by the company and 15 filed against it; 27 cases are pending. The company has 8 deals on record (5 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹20 Lakh; the latest was in March 2022. Its 5 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 2 smaller; the largest is Sciex India Private Limited with revenue of ₹262.05 Cr.
A.S.Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0006774). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aspharma.co.in.
Company details
Recognitions & Rankings of A.S.Pharma
Contact details
A.S.Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is aspharma.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressD – 10/7 Okhla Industrial Area, Phase – 2, New Delhi, Delhi, India – 110020
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of A.S.Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
A.S.Pharma operates one associated brand: AS Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distributes super-specialty pharmaceutical products via an extensive cold-chain network. | aspharma.co.in |
Business activity
The main business activity of A.S.Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of A.S.Pharma Private Limited, buy the company report.
Financials of A.S.Pharma Private Limited
FY 2024 filings availableA.S.Pharma Private Limited reported revenue of ₹255.15 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 10% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.8 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.98 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of A.S.Pharma Private Limited, buy the company report.
Board of directors of A.S.Pharma Private Limited
A.S.Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Dudeja Also directs: Vesta Healthcare Private Limited, Vakratund Hospitalities Private Limited, JD Homes and Hospitalities Private Limited and 1 more | Director | 22 Apr 2010 | 16 Years 6 Months | Current |
| Santosh Kumar Dudeja Also directs: Medira Healthcare Limited, Vesta Healthcare Private Limited, Nuforever Luxury Limited and 5 more | Director | 28 Sep 2005 | 21 Years 1 Months | Current |
| Nippun Dudeja Also directs: Nuforever Luxury Limited, J H Trading and Fincap Limited, Biostringen Labs Private Limited and 2 more | Director | 04 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
A.S.Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sciex India Private Limited | ₹262.05 Cr (FY 2025) | 51.0% | Mumbai, Maharashtra, India | |||
| Lucky Pharmaceuticals Private Limited | ₹261.97 Cr (FY 2021) | -10.0% | Hyderabad, Telangana, India | |||
| Model Enterprises Private Limited | ₹258.33 Cr (FY 2025) | 27.0% | New Delhi, Delhi, India | |||
| A.S.Pharma Private Limitedthis company | ₹255.15 Cr (FY 2025) | ₹2.98 Cr | 1.2% | 10.0% | 25 | New Delhi, Delhi, India |
| Ids Denmed Private Limited. | ₹254.58 Cr (FY 2024) | 15.0% | New Delhi, Delhi, India | |||
| Nishchem International Private Limited | ₹250.06 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of A.S.Pharma Private Limited, buy the company report.
Auditor
A.S.Pharma Private Limited is audited by A.N. KHURANA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.N. KHURANA & CO. | FY 2023 | 012207N |
Shareholding
The shareholding of A.S.Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of A.S.Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Nov 2025 | 101183884 | Hdfc Bank Limited | ₹11.78 Cr | Open | |
| 18 Mar 2025 | 101090674 | Hdfc Bank Limited | ₹20 Cr | Open | |
| 06 Feb 2023 | 100679258 | Others | ₹10 Cr | Open | |
| 12 Dec 2022 | 100659378 | Citi Bank N.A. | ₹20 Cr | Open | |
| 11 Sep 2020 | 100382081 | Others | ₹2.8 Cr | Open |
To see the full charge records of A.S.Pharma Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
A.S.Pharma Private Limited has 8 deals on record (5 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹20 Lakh; the latest was in March 2022.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Santosh Dudeja Huf, 2 individuals Seller: Sunder Dass Dudeja Huf, 3 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Mar 2019 | Rights issue | ₹2.65 Cr | Investors: J H Trading Fincap Limited, 3 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Om Finlease Private Limited , Manbhavan Infotech Private Limited , Sandal Projects & Construction Private Limited |
| Mar 2010 | Funding round | ₹20 Lakh | Investors: Om Finlease Private Limited , Sandal Projects & Construction Private Limited, Manbhavan Infotech Private Limited |
To see the full deal history of A.S.Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
A.S.Pharma Private Limited has 42 court cases on record: 27 filed by A.S.Pharma, 15 filed against it. 27 cases are pending and 15 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 39 | 13 | 26 |
| High courts | 2 | 2 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 42)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jammu, Jammu and Kashmir | Court case (Commerical Suit) | Filed against the company by M/S BDS the Best Marketing Pvt Ltd Through Sandeep Gupta and 2 others | Pending |
| District court, Jammu, Jammu and Kashmir | Court case (Complaint) | Filed against the company by M/S BDS the Best Marketing Pvt Ltd THR Sandeep Gupta | Pending |
| High Court of Delhi | Court case (CM(M)) | Filed against the company by Nayati Medical Private Limited | Pending |
| District court, Faridabad, Haryana | Commercial suit | Filed by the company against Azzurra Pharmaconutrition Private Limited and 3 others | Pending |
| District court, South East, Delhi | Cheque dishonour complaint | Filed by the company against BDS the Best Marketing Pvt Ltd | Pending |
To see the full case history of A.S.Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for A.S.Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
A.S.Pharma Private Limited has a workforce of 25 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
A.S.Pharma has 10 GST registrations: 9 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCA5703N1ZK | Delhi | Active | 01 Jul 2017 |
| 04AAFCA5703N1ZQ | Chandigarh | Active | 01 Jul 2017 |
| 18AAFCA5703N1ZH | Assam | Active | 15 Aug 2019 |
| 21AAFCA5703N1ZU | Odisha | Active | 03 Oct 2020 |
To see the full GST registrations and return filing status of A.S.Pharma Private Limited, buy the company report.
Recent activity
A.S.Pharma Private Limited has 4 board changes on record since 2005: 3 appointments and 1 cessation. The latest: Anju Rani ceased to be Director on 05 Apr 2022.
8 earlier events are in the company report.
Frequently asked questions
A.S.Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 28 September 2005 (21+ years old) and is registered under CIN U24232DL2005PTC141246.
A.S.Pharma has 3 current directors:
- Ajay Dudeja - Director
- Santosh Kumar Dudeja - Director
- Nippun Dudeja - Director
The latest financial statements of A.S.Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of A.S.Pharma is 07AAFCA5703N1ZK, registered in Delhi. The company has 10 GST registrations in all, of which 9 are active and 1 is cancelled or inactive. Other active GSTINs include 04AAFCA5703N1ZQ (Chandigarh), 18AAFCA5703N1ZH (Assam), 21AAFCA5703N1ZU (Odisha).
The CIN (Corporate Identification Number) of A.S.Pharma is U24232DL2005PTC141246. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
A.S.Pharma has 42 court cases on record: 27 filed by the company and 15 filed against it. 27 are pending. Most are in the district courts.
A.S.Pharma was incorporated on 28 September 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
A.S.Pharma has 8 deals on record (5 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹20 Lakh; the latest was in March 2022.
The peers of A.S.Pharma by revenue are Sciex India Private Limited, Lucky Pharmaceuticals Private Limited, Model Enterprises Private Limited, Ids Denmed Private Limited, Nishchem International Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Anju Rani ceased to be Director on 05 Apr 2022. Nippun Dudeja was appointed as Director on 04 Apr 2022. Ajay Dudeja was appointed as Director on 22 Apr 2010. A.S.Pharma has 4 board changes on record in total.
Yes, A.S.Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-08-0006774).

